|
News
-
12.06.2021Perkins Coie Announces 2022 Counsel PromotionsPress ReleasesPerkins Coie is pleased to announce that 47 attorneys have been promoted to the firm’s counsel position, effective January 1, 2022.
-
10.29.2018Perkins Coie Attorneys Mentioned in Law360 - NJ Judge Invalidates Patent for Janssen Cancer Drug ZytigaGeneral NewsShannon M. Bloodworth, Brandon M. White, Maria A. Stubbings and Bryan D. Beel were mentioned as counsel for Mylan in the Law360* article, "NJ Judge Invalidates Patent for Janssen Cancer Drug Zytiga," regarding the invalidation of a patent that covered Janssen Biotech Inc.’s oncology medication, Zytiga.
*Subscription-based publication -
05.15.2018Perkins Coie Announces Life Sciences Blog: 1600 PTAB & BeyondPress ReleasesPerkins Coie is proud to announce the launch of 1600 PTAB & Beyond, a blog that reports from the intersection of the life sciences industry and key decisions and developments from the Patent Trial and Appeal Board (PTAB), district courts and appellate courts.
